Molecular Dissociation of the Role of PSD-95 in Regulating Synaptic Strength and LTD
Overview
Authors
Affiliations
The postsynaptic density protein PSD-95 influences synaptic AMPA receptor (AMPAR) content and may play a critical role in LTD. Here we demonstrate that the effects of PSD-95 on AMPAR-mediated synaptic responses and LTD can be dissociated. Our findings suggest that N-terminal-domain-mediated dimerization is important for PSD-95's effect on basal synaptic AMPAR function, whereas the C-terminal SH(3)-GK domains are also necessary for localizing PSD-95 to synapses. We identify PSD-95 point mutants (Q15A, E17R) that maintain PSD-95's influence on basal AMPAR synaptic responses yet block LTD. These point mutants increase the proteolysis of PSD-95 within its N-terminal domain, resulting in a C-terminal fragment that functions as a dominant negative likely by scavenging critical signaling proteins required for LTD. Thus, the C-terminal portion of PSD-95 serves a dual function. It is required to localize PSD-95 at synapses and as a scaffold for signaling proteins that are required for LTD.
PSD-95 Protein: A Promising Therapeutic Target in Chronic Pain.
Ma L, Sun D, Wen S, Yuan J, Li J, Tan X Mol Neurobiol. 2024; 62(3):3361-3375.
PMID: 39285025 DOI: 10.1007/s12035-024-04485-x.
Zhang Z, Chen S, Jun S, Xu X, Hong Y, Yang X Autophagy. 2024; 21(2):424-446.
PMID: 39193909 PMC: 11759533. DOI: 10.1080/15548627.2024.2395727.
Activity-dependent diffusion trapping of AMPA receptors as a key step for expression of early LTP.
Nowacka A, Getz A, Bessa-Neto D, Choquet D Philos Trans R Soc Lond B Biol Sci. 2024; 379(1906):20230220.
PMID: 38853553 PMC: 11343219. DOI: 10.1098/rstb.2023.0220.
DHHC2 regulates fear memory formation, LTP, and AKAP150 signaling in the hippocampus.
Li M, Wang L, Zheng Y, Huang D, Xia Z, Liu J iScience. 2023; 26(9):107561.
PMID: 37664599 PMC: 10469764. DOI: 10.1016/j.isci.2023.107561.
A review of remote ischemic conditioning as a potential strategy for neural repair poststroke.
Yu W, Ren C, Ji X CNS Neurosci Ther. 2022; 29(2):516-524.
PMID: 36550592 PMC: 9873528. DOI: 10.1111/cns.14064.